| Emergency Preparedness Resources and Links for Healthcare Professionals and Healthcare Facilities |
|
AHRQ Bio-terrorism Readiness Evaluation Tool for Healthcare Facilities
http://www.ahrq.gov/about/cpcr/bioterr.pdf
The information and data obtained from this questionnaire will be used to help assess the preparedness and capacity of your hospital to respond to and treat victims of biological incident.
|
|
Centers for Disease Control and Prevention Public Health Emergency Preparedness and Response
http://www.bt.cdc.gov
The CDC has assembled a stellar site on bio-terrorism preparedness. It includes a listing of biological agents/diseases and chemical agents that links to comprehensive medical information about these agents. A section on planning includes information hospitals can use to develop preparedness procedures and policies. A section on state and local preparedness provides a map of the United States that links to individual state assessments of their preparedness status. There is even a section with a model emergency communications plan, and a place where the media can obtain fact sheets about the different agents.
|
|
Cipro Treatment for Anthrax
http://www.fda.gov/medwatch/safety/2001/safety01.htm#cipro
FDA reminds all health professionals and the general public that Cipro is approved for the inhaled form of anthrax after an individual has been exposed. Safety and effectiveness in pediatric patients and adolescents less than 18 years of age have not been established, except for use in inhalational anthrax (post-exposure). The FDA Center for Drug Evaluation and Research has posted a comprehensive web page on the use of Cipro for inhalational anthrax.
|
|
Doxycycline Treatment for Anthrax
http://www.fda.gov/cder/drug/infopage/doxycycline/advisory.htm
FDA reminds all health professionals and the general public that Doxycycline is approved for the treatment of anthrax in all its forms. The FDA is providing additional information concerning the dosing regimen for the treatment of anthrax, including cutaneous and inhalation anthrax (post-exposure). The currently recommended dosage regimen of doxycycline for severe disease is 100 mg every 12 hours for adults and 1mg per pound (2.2mg per kilogram) every 12 hours for children less than 100 pounds. These dosage regimens are appropriate for use in patients who have been exposed to anthrax (Bacillus anthracis) regardless of the route of exposure.
|
|
National Academies Press: Responding First to Bioterrorism
http://www.nap.edu/firstresponders/In_site_indexes.html
A page with links to bioterrorism-related information within a single site.
|
|
University of Nebraska Medical Center's Readiness and Response to Bioterrorism
http://www.unmc.edu/bioterrorism/
In response to recent bio-terrorist attacks, the University of Nebraska Medical Center offers its resources to answer questions and address concerns. Our experts in infectious disease, emergency response and research are monitoring the situation and responding to requests from across the nation for assistance and guidance.
|
|